Alector (ALEC) Debt Ratio (2024 - 2026)

Alector (ALEC) posted quarterly Debt Ratio of 0.04 for Q1 2026, up 75.63% year-over-year from 0.02 in Q1 2025, and up 23.21% quarter-over-quarter from 0.03 in Q4 2025.

Alector (ALEC) Debt Ratio (2024 - 2026) Analysis & Trends

Alector (ALEC) has reported Debt Ratio for 3 consecutive years, with 0.04 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Debt Ratio rose 75.63% year-over-year to 0.04; the TTM figure through Mar 2026 stood at 0.04 (up 75.63% YoY), while the FY2025 annual figure was 0.03, up 64.8% from the prior year.
  • Debt Ratio grew to 0.04 in Q1 2026 per ALEC's latest filing, from 0.03 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.04 in Q1 2026 and bottomed at 0.02 in Q4 2024.
  • Historically, Debt Ratio has averaged 0.03 across 3 years, with a median of 0.03 in 2025.
  • Annual changes were most pronounced in 2025 — Debt Ratio jumped 64.8% — and 2026, when it soared 75.63%.
  • Alector's Debt Ratio stood at 0.02 in 2024, then jumped by 64.8% to 0.03 in 2025, then gained by 23.21% to 0.04 in 2026.
  • Business Quant data shows ALEC's Debt Ratio at 0.04 in Q1 2026, 0.03 in Q4 2025, and 0.03 in Q3 2025.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 0.05
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 0.12
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - 0.47
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 0.26
10 Alector 218.85 Mn 46.05 Mn - 0.05

Historic Data

Download Data
DateValue
Jun 30, 2026 0.05
Mar 31, 2026 0.04
Dec 31, 2025 0.03
Sep 30, 2025 0.03
Jun 30, 2025 0.03
Mar 31, 2025 0.02
Dec 31, 2024 0.02